Bachelor of Science in Pharmacy (BScPharm) - University of Alberta, 1988
Hospital Pharmacy General Clinical Residency - Royal Columbian Hospital, New Westminster BC, 1989
Doctor of Pharmacy (PharmD) - State University of New York at Buffalo, New York, 1992
Clinical Register, Alberta College of Pharmacists
Additional Prescribing Authorization (APA) since 2007
North American Menopause Society (NAMS) Certified Menopause Practitioner (NCMP)
Awards and Honours (Selected)
Osteoporosis Canada Backbone Award, 2019
Canadian Pharmacist of the Year (Canadian Pharmacists Association), 2016
Faculty of Merit Award for 2012, University of Alberta, 2013
CSHP Alberta Branch Enhancing Pharmacy Practice Recognition Program, 2011
Rutherford Award for Excellence in Undergraduate Teaching, University of Alberta, 2011
Canadian Pharmacists Association (CPhA) Patient Care Achievement Award for Specialty Practice, 2011
APEX Award of Excellence Award (Alberta College of Pharmacists and Alberta Pharmacists Association), 2011
Alberta Pharmacy Centennial Award of Distinction, 2011
Bristol Myers Squibb Teaching Excellence Award, 2010
CSHP AB Branch, Enhancing Patient Care through Prescribing Recognition Award, 2009
Honourable Mention, Bristol Myers Squibb Teaching Excellence Award, 2009
Fellow, Canadian Society of Hospital Pharmacists (CSHP), 2008
Canadian College of Clinical Pharmacists (CCCP) Merck Frosst Meritorious Service Award, 2005
Practitioner Award 1998, CSHP Alberta Branch, 1998
Menopause Clinic, Lois Hole Hospital for Women at RAH site
Multidisciplinary Bone Health Clinic, Kaye Clinic
Professional Service/Committees (Selected)
Osteoporosis Canada (OC) Scientific Advisory Committee (SAC), Executive Committee and SAC consultant
Board of Directors, Canadian Menopause Society
Chair, Canadian Pharmacists Association (CPhA) Editorial Advisory Committee
My goals of my research program are summarized as follows:
1. To study aspects of women’s health to enhance our understanding of specific issues in women’s health and improve the quality of care of women.
2. To evaluate interventions to identify patients at high risk for osteoporotic fractures and to enhance the care of patients with osteoporosis.
3. To develop innovative techniques to influence pharmacists’ practice specifically in the areas of women’s health and osteoporosis.
Selected Publications (last 5 years) (* represents corresponding author, trainees are underlined)
Siyam T, Shivji A, Ross S, Eurich D, Lavasanifar A, Yuksel N* Developing and evaluating a patient decision aid for hormone therapy to manage symptoms of surgical menopause: The story behind The “SheEmpowers” patient decision aid. Menopause. In press
Woit, C, Yuksel N, Charrois T.* Pharmacy and medical students’ competence and confidence with prescribing: A cross-sectional study. Curr Pharm Teach Learn 2020;12:1311-1319
Sydora, B., Turner, C., Malley, A., Davenport, M., Yuksel, N., Shandro, T., Ross, S.* Can walking exercise programs improve health for women in menopause transition and postmenopausal? Findings from a scoping review Menopause 2020;27(8):952-963 https://dx.doi.org/10.1097/gme.0000000000001554
Woit, C., Yuksel, N., Charrois, T.* Competence and confidence with prescribing in pharmacy and medicine: a scoping review. Int J Pharm Pract 2020;28:312-25 https://dx.doi.org/10.1111/ijpp.12595
Sydora BC*, Yuksel N, Chadha V, Battachio L, Reich-Smith L, Hagen S, Yaskina M, Shandro M, Ross SJ. Change over time in patient-reported symptoms and quality of life in Edmonton’s Interdisciplinary Menopause Clinics: Preliminary cohort study of clinic patients and waitlist patients. Menopause 2019;26(9):1031-7.
Marcinkow A, Parkhomchik P, Schmode A, Yuksel N*. The quality of information on combined oral contraceptives available on the Internet. J Obstet Gynaecol Can 2019;41(11):1599-1607.
Faruque CF, Guirguis LM*, Hughes, CA, Makowsky MJ, Sadowski CA, Schindel TJ, Cor K, Yuksel, N. Characterizing pharmacist prescribers in Alberta using cluster analysis. J Pharm Health Service Research 2019;10:5-12.
Siyam T, Carbon J, Ross S, Yuksel N*. Determinants of hormone therapy decision-making after bilateral oophorectomy (BO): A narrative review. Maturitas 2019;120:68-76
Schindel TJ, Yuksel N, Breault R, Daniels J, Varnhagen S, Hughes CA*. Pharmacists’ learning needs in the era of expanding scopes of practice: Evolving practices and changing needs. Res Social Admin Pharm 2019;15(4):448-458.
Sehn E, Mozak C, Yuksel N, Sadowski C*. An analysis of online content related to testosterone supplementation. The Aging Male 2019;22(2):141-9
Guirguis LM*, Hughes CA, Makowsky M, Sadowski CA, Schindel TJ, Yuksel N, Faruquees CF. Development and validation of a survey instrument to measure factors that influence pharmacist prescribing. Pharmacy Practice 2018;16(1):1068
Siyam T, Ross S, Shandro T, Hagen S, Battochio L, Yuksel N*. Perspectives and decision-making about menopausal therapies in women who had a bilateral oophorectomy. Menopause 2018;25(7):795-802 DOI 10.1097/GME.0000000000001069.
Siyam T, Sultani H, Ross S, Chatterley T, Yuksel N*. Evaluating the content and development of decision aid tools for the management of menopause: A scoping review. Maturitas 2017;106:80-86. https://doi.org/10.1016/j.maturitas.2017.09.006
Kwon S, Wang A, Sadowski C, Yuksel N, Doschak MR*. Urinary bone turnover markers as target indicators for monitoring bisphosphonate drug treatment in the management of osteoporosis. Curr Drug Targets 2018;19(5):451-9
Sydora BC, Yuksel N, Veltri NL, Marillier J, Sydora CP, Yaskina M, Battochio L, Shandro TML, Ross S*. Patient characteristics, menopausal symptoms, and care provided at an interdisciplinary menopause: retrospective chart review. Menopause 2018;25(1):102-105
Yuksel N*, Brochu L, Malik B, Ogbogu U. Promotion and marketing of bioidentical hormone therapy on the internet: A content analysis of websites. Menopause 2017;24(10):1129-35. (Editorial: This article was editorialized in Menopause 2017;24(10):1116-17)
Siyam T, Ross S, Campbell S, Eurich DT, Yuksel N*. The effect of hormone therapy on quality of life and breast cancer risk after risk-reducing salpingo-oopherectomy: a systematic review. BMC Women’s Health 2017;17(1):22. doi: 10.1186/s12905-017-0370-6.
Schindel TJ, Yuksel N, Breault R, Daniels J, Varnhagen S, Hughes CA*. Perceptions of Pharmacists' Roles in an Era of Expanding Scopes of Practice. Res Social Adm Pharm 2017;13(1):148-161.
Guirguis L*, Hughes C, Makowsky M, Sadowski C, Schindel T, Yuksel N. Survey of pharmacist prescribing in Alberta. Am J Health-Syst Pharm 2017;74(2):62-69
Sydora B, Fast H, Campbell S, Yuksel N, Lewis JE, Ross SJ*. Use of the Menopause-Specific Quality of Life (MENQOL) questionnaire in research and clinical practice: a comprehensive scoping review. Menopause 2016;23(9):1038-51.
Schindel TJ, Yuksel N, Breault R, Daniels J, Varnhagen S, Hughes CA*. Perceptions of Pharmacists' Roles in an Era of Expanding Scopes of Practice. Res Social Adm Pharm 2017;13(1): 148-161.
Sadoswki CA, Lyder C, Yuksel N* Beliefs and current practices of pharmacists with bisphosphonate use for osteoporosis in patients with renal insufficiency. Can J Hosp Pharm 2016;69(1):14-22.
Croden J, Ross S, Yuksel N, Sydora BC*. A survey of the availability in Canadian pharmacy chains of over-the-counter natural health products for menopause symptoms. BMC Complement Altern Medicine 2015;15(1): 86. doi: 10.1186/s1290601506085.
Shifren JL*, Gass MLS for the NAMS Recommendations for Clinical Care of Midlife Women Working Group (note: part of working group). The North American Menopause Society Recommendations for Clinical Care of Midlife Women. Menopause 2014;21(10):1-25.
Wang E, Marnoch C, Khurana R, Sia W, Yuksel N*. Hemorrhagic complications of peripartum anticoagulation: A Retrospective Chart Review. Obstet Med 2014;7(2):77-83
Guirguis LM, Makowsky M*, Hughes C, Sadowski C, Yuksel N. How have pharmacists in different practice settings integrated prescribing privileges into practice in Alberta? A Qualitative Exploration. J Clin Pharm Ther 2014 Aug;39(4):390-8.
Hughes C, Makowsky M, Sadowski C, Schindel T, Yuksel N, Guirguis LM*. What prescribing means to pharmacists: A qualitative exploration of practicing pharmacists in Alberta. Int J Pharm Pract. 2014;22:283-291.
“Not having heard something is not as good as having heard it;
having heard it is not as good as having seen it;
having seen it is not as good as knowing it;
knowing it is not as good as putting it into practice.”
Xunzi, chinese proverb
At the heart of my teaching philosophy is creating an effective learning environment in the classroom and in the clinical setting. The learning environment is critical in making students feel comfortable with applying knowledge and participating in the learning process. I strive to create an environment that is conducive to learning and motivating to students. I believe the environment is set by displaying passion in what you teach, being committed to the students’ progress and showing that you care about their learning.
My main areas of teaching is in the areas of Sexual and Reproductive Health (including hormonal contraception, menopause, menstrual related disorders, Endometriosis, PCOS, etc), Osteoporosis as well as Gastrointestinal Diseases (ie IBS, IBD etc). I am the lead instructor for a course on Sexual and Reproductive Health and Musculoskeletal Diseases in the 3rd year of the PharmD program.
Students will develop fundamental knowledge in the areas of sexual and reproductive health, as well as musculoskeletal / joint conditions and will apply therapeutic and pharmaceutical science knowledge to various patient care scenarios, with increasing complexity. Students will further develop their critical thinking and self-directed learning skills, along with their breadth and depth of therapeutic knowledge, as they incorporate principles of evidence-based therapeutic decision making within the patient care process framework. (Restricted to Pharmacy students.)Fall Term 2022 Fall Term 2022